Ovarian Cancer Clinical Trials
Ovarian Cancer clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for ovarian Cancer. Corterve aggregates actively recruiting Ovarian Cancer studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Ovarian Cancer studies
- A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsNCT04657068PHASE1, PHASE2Artios Pharma LtdBirmingham, Alabama
- A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian CancerNCT06072781PHASE3Verastem, Inc.Phoenix, Arizona
- A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.NCT06890338PHASE2AbbVieBirmingham, Alabama
- A Phase I Study of SIM0505 in Participants With Advanced Solid TumorsNCT06792552PHASE1NextCure, Inc.Orlando, Florida
- Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic AnalysisNCT01441089National Cancer Institute (NCI)Bethesda, Maryland
- AOH1996 for the Treatment of Refractory Solid TumorsNCT05227326PHASE1City of Hope Medical CenterScottsdale, Arizona
- Clinical Pre-screening Protocol for Ovarian CancerNCT03877796Allarity TherapeuticsTampa, Florida
- A Study of Isoquercetin in People With Ovarian CancerNCT07303894PHASE2Memorial Sloan Kettering Cancer CenterBoston, Massachusetts
- A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian CancerNCT07059845PHASE2AbbVieLa Jolla, California
- Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal HistologiesNCT04847063PHASE1National Cancer Institute (NCI)Bethesda, Maryland
- The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in TamponsNCT03538665University of Alabama at BirminghamBirmingham, Alabama
- Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian CancerNCT06545604NAM.D. Anderson Cancer CenterHouston, Texas
Ovarian Cancer trials by state
Ovarian Cancer trials by metro
Frequently asked questions
- How do I find recruiting Ovarian Cancer clinical trials?
- Corterve aggregates actively recruiting Ovarian Cancer studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Ovarian Cancer clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Ovarian Cancer clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.